Immunotherapy after liver transplantation: Where are we now?

BACKGROUND: There is limited evidence on the safety of immunotherapy use after liver transplantation and its efficacy in treating post-liver transplant hepatocellular carcinoma (HCC) recurrence. AIM: To assess the safety of immunotherapy after liver transplant and its efficacy in treating post-liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Kin Pan, Chok, Kenneth Siu Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Scientometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554723/
https://www.ncbi.nlm.nih.gov/pubmed/34754394
http://dx.doi.org/10.4240/wjgs.v13.i10.1267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554723/
https://www.ncbi.nlm.nih.gov/pubmed/34754394
http://dx.doi.org/10.4240/wjgs.v13.i10.1267

Ejemplares similares